Follow The Filings

INGN Inogen Inc.

Health Care, filed as INOGEN INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

  • 1 Owner
  • Max 1.0%
  • $5.5M

Who owns this now

Largest portfolio weights among holders, up to 1.0% (Nathan Fischel, Dafna Capital Management). Not free-float ownership.

  1. Nathan Fischel 1.0%

Who owns INGN

Sorted by value, long equity only, as of 2026 Q2.

History
Nathan Fischel, Dafna Capital Management 1.0% Hold 845,179 $5.5M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by INGN's executives, directors and 10% owners in the last 12 months, from their Form 4s

All INGN insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • $142K sold by 1 insider under 10b5-1 plans
  1. Boyer Jennifer M Yi EVP Entrprs Enblmnt, Ch HR Off
    Planned sale
    $72K 10,938 shares at $6.60 69% of stake
    Traded Jul 1 Filed Jul 6
    ↗
  2. Boyer Jennifer M Yi EVP Entrprs Enblmnt, Ch HR Off
    Planned sale
    $70K 10,770 shares at $6.53 40% of stake
    Traded May 29 Filed Jun 2
    ↗

Also filed in the last 12 months, not counted as buying or selling: 19 share withholdings for taxes, 18 stock grants, and 15 option exercises.

SEC filings

Recent issuer filings from EDGAR, 16 shown.

Filed Form Detail Links
8-K 1.01,7.01,8.01,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
DEF 14A Filing Doc
8-K 1.01,5.02,7.01,9.01 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
10-K Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $251.61M $278.76M $295.3M
Gross profit $126.7M $154.74M $154.26M
Gross margin * 50.4% 55.5% 52.2%
Net income -$102.45M -$35.89M -$22.75M
Net margin * -40.7% -12.9% -7.7%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $207.07M $185.45M $198.3M
Total non-current assets * $119.13M $110.73M $100.33M
Total assets $326.19M $296.18M $298.62M
Total current liabilities $72.5M $76.69M $63.54M
Total non-current liabilities * $48.89M $45.64M $42.86M
Total equity $204.81M $173.86M $192.23M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$3.23M $5.91M -$11.22M
Cash from investing -$59.32M -$13.98M -$26.21M
Cash from financing $0.96M $0.265M $24.18M
Net change in cash -$61.52M -$8.08M -$12.4M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.